Sleep and cardiometabolic function in obese adolescent girls with polycystic ovary syndrome

详细信息    查看全文

• 作者：Kiran Nandalike^a ; Chhavi Agarwal^b ; Temima Strauss^a ; Susan M. Coupey^c ; Carmen R. Isasi^d ; Sanghun Sin^a ; Raanan Arens^a ; ^{rarens@montefiore.org}
• 关键词：AHI ; apnoea hypopnoea index ; HDL ; high-density lipoprotein ; HOMA-IR ; homeostatic model assessment a measure of Insulin resistance ; MetS ; metabolic syndrome ; OSA ; obstructive sleep apnoea ; PCOS ; polycystic ovary syndrome ; TG ; triglyceride
• 刊名：Sleep Medicine
• 出版年：2012
• 出版时间：December, 2012
• 年：2012
• 卷：13
• 期：10
• 页码：1307-1312
• 全文大小：173 K

文摘

Objective

To compare the polysomnography findings and cardiometabolic function among adolescent girls with polycystic ovary syndrome (PCOS) and matched female and male controls.

Method

Retrospective chart review of electronic medical records of 28 girls with PCOS (age: 16.8 ¡À 1.9 years, body mass index (BMI) Z-score 2.4 ¡À 0.4), 28 control females (age: 17.1 ¡À 1.8, BMI Z-score 2.4 ¡À 0.3) and 28 control males (age: 16.6 ¡À 1.6, BMI Z-score 2.5 ¡À 0.5) in a tertiary care centre.

Results

The prevalence of obstructive sleep apnoea (OSA) was higher in girls with PCOS compared to control females (16/28 (57 % ) vs. 4/28(14.3 % ), p < 0.01); however, it was comparable to that of the control males (16/28(57 % ) vs. 21/28(75 % ), p = 0.4). Girls with PCOS had a significantly higher prevalence of insulin resistance compared to control females and control males (20/28 (71.4 % ) vs. 9/22 (41.0 % ) (p = 0.04) vs. 8/23 (34.8 % ) (p = 0.01). Among girls with PCOS, those with OSA had significantly higher proportions of metabolic syndrome (MetS) (9/16 (56.3 % ) vs. 1/12 (8.3 % ) p = 0.03), higher insulin resistance (14/16 (87.5 % ) vs. 6/12 (50 % ), p = 0.04), elevated daytime systolic blood pressure (128.4 ¡À 12.8 vs. 115.6 ¡À 11.4, p < 0.01), lower high-density lipoprotein (HDL) (38.6 ¡À 8.7 vs. 49 ¡À 10.9, p = 0.01) and elevated triglycerides (TG) (149.7 ¡À 87.7 vs. 93.3 ¡À 25.8, p = 0.03) compared to those without OSA.

Conclusions

We report a higher prevalence of OSA and metabolic dysfunction in a selected group of obese girls with PCOS referred with sleep-related complaints compared to BMI-matched control girls without PCOS. We also report higher prevalence of cardiometabolic dysfunction in girls with PCOS and OSA compared to girls with PCOS without OSA.